Literature DB >> 16892779

Anaphylaxis: a review of 601 cases.

Luke M Webb1, Phil Lieberman.   

Abstract

BACKGROUND: The allergist usually sees patients with anaphylaxis after the event for the purposes of identifying the cause, establishing a prognosis, and preventing further episodes. Knowledge of the characteristics of such patients is essential to achieve these goals.
OBJECTIVE: To examine the natural history, clinical manifestations, and factors that affect the patients' adherence to suggested treatment and preventive strategies of anaphylaxis.
METHODS: A retrospective medical record review spanning 25 years (1978-2003) and follow-up questionnaires were used to obtain data on 601 patients who presented with anaphylaxis of unknown origin to a private university-affiliated allergy-immunology practice.
RESULTS: Patients ranged in age from 1 to 79 years, with a mean age of 37 years. Females comprised 62% of cases. Causes of anaphylaxis were elucidated in 41% of cases. Known causes included foods in 131 patients (22%), medications in 69 cases (11%), and exercise in 31 cases (5%). Two hundred twenty-three patients (37%) were found to be atopic by history confirmed with skin prick testing. The most common manifestation was urticaria and/or angioedema, reported in 87% of patients. Systemic mastocytosis was found in 3 patients. Episodes tended to decline in frequency with time. Adherence to instructions to carry epinephrine can be improved with more effective teaching.
CONCLUSIONS: In most cases, the cause of anaphylaxis is undetermined. Women are affected more commonly than men. Systemic mastocytosis should be considered in cases of idiopathic anaphylaxis, and patients with a history of atopy are at an increased risk of developing anaphylaxis. Patients are more reliably carrying epinephrine as a result of changes in physician instructions. Finally, anaphylactic episodes tend to decrease in frequency and severity with time.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16892779     DOI: 10.1016/S1081-1206(10)61367-1

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  50 in total

1.  Oral muscle relaxant may induce immediate allergic reactions.

Authors:  Gyu-Young Hur; Eui Kyung Hwang; Jae-Young Moon; Young-Min Ye; Jae-Jeong Shim; Hae-Sim Park; Kyung-Ho Kang
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

Review 2.  Update on food allergy in adults.

Authors:  Rabia Quddus Chaudhry; John J Oppenheimer
Journal:  Curr Allergy Asthma Rep       Date:  2012-08       Impact factor: 4.806

3.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

Review 4.  Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis.

Authors:  James L Kuhlen; Yamini V Virkud
Journal:  Discov Med       Date:  2015-02       Impact factor: 2.970

5.  International survey of knowledge of food-induced anaphylaxis.

Authors:  Julie Wang; Michael C Young; Anna Nowak-Węgrzyn
Journal:  Pediatr Allergy Immunol       Date:  2014-10-16       Impact factor: 6.377

Review 6.  Epidemiology and risk factors for drug allergy.

Authors:  Bernard Y-H Thong; Teck-Choon Tan
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

7.  Perinatal androgens organize sex differences in mast cells and attenuate anaphylaxis severity into adulthood.

Authors:  Emily Mackey; Kyan M Thelen; Vedrana Bali; Mahsa Fardisi; Madalyn Trowbridge; Cynthia L Jordan; Adam J Moeser
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-11       Impact factor: 11.205

8.  Anaphylaxis and mast cell disease: what is the risk?

Authors:  Cem Akin
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

9.  Navigating the updated anaphylaxis parameters.

Authors:  Stephen F Kemp
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

10.  Recent advances in mast cell clonality and anaphylaxis.

Authors:  Cem Akin
Journal:  F1000 Med Rep       Date:  2009-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.